Baidu
map

The belated US FDA approval of the adenosine A(2A) receptor antagonist istradefylline for treatment of Parkinson's disease

Chen, JF; Cunha, RA

Chen, JF (corresponding author), Wenzhou Med Univ, Mol Neuropharmacol Lab, Wenzhou, Peoples R China.

PURINERGIC SIGNALLING, 2020; 16 (2): 167

Abstract

After more than two decades of preclinical and clinical studies, on August 27, 2019, the US Food and Drug Administration (FDA) approved the adenosine ......

Full Text Link


Baidu
map
Baidu
map
Baidu
map